Myriad Genetics, Inc. (NASDAQ:MYGN) Q1 2025 Earnings Call Transcript May 6, 2025
Myriad Genetics, Inc. beats earnings expectations. Reported EPS is $-0.03, expectations were $-0.05.
Operator: Welcome to the Myriad Genetics First Quarter 2025 Financial Earnings Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Matt Scalo, Senior Vice President of Investor Relations. Please go ahead.
Matt Scalo : Good afternoon, and welcome to the...
